MS vs TMO: Which Is the Better Buy?
Side-by-side comparison of Morgan Stanley and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Morgan Stanley · Financial Services
$189.30
-30.5% upside to fair value
Grade C
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
TMO has more upside to fair value
(+10.1%).
MS trades at a lower forward P/E
(16.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MS |
TMO |
| Current Price |
$189.30 |
$462.60 |
| Fair Value Estimate |
$131.49 |
$509.20 |
| Upside to Fair Value |
-30.5%
|
+10.1%
|
| Market Cap |
$300.6B |
$171.9B |
| Forward P/E |
16.4x
|
25.1x
|
| EV / EBITDA |
24.4x
|
19.0x
|
| Price / Sales |
2.5x
|
3.8x
|
| Price / FCF |
-16.8x
|
25.5x
|
| Revenue Growth YoY |
+18.8%
|
+6.2%
|
| Gross Margin |
58.0%
|
39.4%
|
| Operating Margin |
19.5%
|
17.8%
|
| Return on Equity |
16.7%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
—
|
3.92%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Morgan Stanley is a leading global financial services firm operating in Institutional Securities, Wealth Management, and Investment Management. The company benefits from a durable competitive moat supported by its systemically important status, diversified revenue streams, and strong management with a 36-year veteran CEO. Despite solid fundamentals including 14.2% revenue growth in 2025 and 16.7%…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
MS |
TMO |
| Zone Low |
$98.62 |
$381.90 |
| Zone High |
$111.77 |
$432.82 |
| In Buy Zone? |
No
|
No
|